How Can We Accelerate New Drug Development for Children with Cancer? | Second Global Oncothon
Welcome to the Second Global Oncothon in collaboration with SIOP. In this special session, moderated by Shushan Hovsepyan, four distinguished leaders in pediatric oncology share their visions for the future of pediatric drug development, innovation in targeted and immunotherapies, and the global collaborations needed to bring new treatments to children everywhere. Our guests include:
Dr. Michela Casanova – Pediatric Oncologist at the National Cancer Institute in Milan, Board Member of SIOP, and active leader in ITCC initiatives.
Professor Gregory Reaman – Scientific Director of the Childhood Cancer Data Initiative at the U.S. National Cancer Institute and former Director of Pediatric Oncology at the FDA’s Oncology Center of Excellence.
Professor Nai-Kong Cheung – Head of the Neuroblastoma Program at Memorial Sloan Kettering Cancer Center, renowned for his pioneering work in antibody-based therapies for childhood cancers.
Janneke van der Kamp – CEO of Norgine Pharma, bringing a pharmaceutical industry perspective to the challenges and opportunities in pediatric oncology drug development.
Key topics explored:
- Overcoming economic and regulatory challenges to bring pediatric-specific therapies to market
- Lessons from adult oncology and adapting them to childhood cancer treatment
- The role of precision medicine, CAR T cells, antibody-drug conjugates, and degraders in the pediatric space
- The importance of survivorship and improving quality of life post-treatment
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023